Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Submitted by
admin
on April 17, 2010 - 12:53pm
Source:
Pharmabiz
News Tags:
Novartis
Emisphere
Eligen Technology
PTH1-34
osteoporosis
Headline:
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Do Not Allow Advertisers to Use My Personal information
